36.19
+0.31(+0.86%)
Currency In USD
| Previous Close | 35.88 |
| Open | 35.8 |
| Day High | 36.24 |
| Day Low | 35.78 |
| 52-Week High | 36.33 |
| 52-Week Low | 24.05 |
| Volume | 2.99M |
| Average Volume | 4.95M |
| Market Cap | 20.35B |
| PE | 14.77 |
| EPS | 2.45 |
| Moving Average 50 Days | 33.64 |
| Moving Average 200 Days | 30.3 |
| Change | 0.31 |
If you invested $1000 in Royalty Pharma plc (RPRX) since IPO date, it would be worth $896.9 as of July 03, 2025 at a share price of $36.19. Whereas If you bought $1000 worth of Royalty Pharma plc (RPRX) shares 3 years ago, it would be worth $894.91 as of July 03, 2025 at a share price of $36.19.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
GlobeNewswire Inc.
Jun 24, 2025 11:05 AM GMT
Up to $1.25 billion ($250 million upfront) of synthetic royalty funding and up to $750 million in secured debt Innovative partnership enables Revolution Medicines to retain control over pipeline development and global commercialization of daraxonrasi
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire Inc.
Jun 04, 2025 8:15 PM GMT
NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025 at 2:00 p.m. ET. The w
Royalty Pharma Completes the Acquisition of Its External Manager
GlobeNewswire Inc.
May 16, 2025 8:30 PM GMT
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC (“RP Management”). The acquisition received overwhelming suppor